DTC's reputation as a bully may be largely overstated. There's little evidence that sales of specific drugs increase.
If clinical mistakes were as common as clerical ones, nobody would leave a hospital alive. Something needs to be done, and done soon.
There aren't enough geriatricians to go around, but judicious use of these specialists can still do a lot for an aged population.
A significant number of consultants, insurers, politicians, and, oh yes, the companies that purchase health care are increasing their interest.
The company's Mid-Atlantic States Region has seen impressive savings since launching one of its disease management programs.
A Conversation with John Sory
As a vice president of Pfizer Health Solutions, a major DM company, John Sory knows how difficult it is to bring systematic care to the chronically ill.
The $60 billion to $108 billion that could be saved through tort reform would help 2.4 million to 4.3 million uninsured get coverage, the government claims.
A single strand of nucleic acid may hold the key to treating the leading cause of severe vision loss and blindness resulting from age-related macular degeneration.
A consortium of employers is paying the pharmacy benefit manager a new administration fee but taking all rebates and discounts.
The Formulary Files
Managed Care Outlook
Standardizing health plan administrative processes and eliminating duplication of effort would go a long way toward strengthening the doctor-insurer relationship.